Hydrogel Spacer Coverage Clarified — Photon EBRT Only (Apr 2026)

Effective 04/04/2026 Blue Cross Blue Shield of Louisiana restates coverage for implanted hydrogel spacers used with definitive photon-based external beam radiation for prostate cancer, specifying eligible photon modalities as 3D conformal, IMRT, and SBRT. Use of hydrogel spacers with prostate brachytherapy, proton beam therapy (PBT), or any indications beyond the listed photon modalities is deemed not medically necessary. Coverage remains subject to the member’s contract/certificate and fulfillment of the policy’s medical necessity criteria; the policy is based on peer-reviewed literature, specialty guidance, and physician input. Contractual language and applicable federal/state law take precedence over the policy.

What changed in this revision

The current effective date is 04/04/2026; the document lists an original effective date of 07/01/2019. This version restates the coverage determination for implanted hydrogel spacers used during definitive external beam radiation therapy for prostate cancer and clarifies the modalities considered eligible. The policy continues to tie coverage to the member's contract/certificate and the fulfillment of medical necessity criteria.

The revision explicitly lists the eligible external beam photon modalities as 3D conformal, IMRT, and SBRT. It also reaffirms exclusions by explicitly naming proton beam therapy (PBT) and prostate brachytherapy as uses that are considered not medically necessary based on the Company’s review of available data.

Eligible indication: hydrogel spacer with photon external beam radiation

The policy states that the Company may consider an implanted hydrogel spacer between the prostate and rectum to be eligible for coverage when used in conjunction with primary definitive radiation therapy for prostate cancer delivered by photon-based external beam radiation. The explicit photon modalities listed are 3D conformal, IMRT, and . Coverage is contingent on benefits being available under the member’s contract/certificate and meeting the policy’s medical necessity criteria.

Explicit non-covered indications: brachytherapy and proton therapy

The policy expressly considers hydrogel spacer use for prostate brachytherapy and for proton beam therapy (PBT) to be not medically necessary. It further states that use of an implanted hydrogel spacer for "all other indications" beyond the listed eligible photon-based external beam modalities is considered not medically necessary based on the Company’s review of available data.

These exclusions are presented as firm categorical determinations rather than conditional or case-by-case denials; the policy does not provide exceptions or criteria under which these non-covered indications might become eligible.

Medical necessity definition and policy hierarchy

The policy reiterates the Company’s definition of Medically Necessary care, specifying that services must be consistent with nationally accepted standards of medical practice, clinically appropriate, and not primarily for patient or provider convenience or more costly than an equivalent alternative. The policy references reliance on peer‑reviewed literature, specialty society recommendations, and practicing physician views as the basis for these determinations.

The document also notes contractual and legal precedence: if a member’s health insurance contract defines coverage differently, that contract language will be relied upon for specific coverage determinations. It emphasizes that medical policies are scientific-based opinions for coverage determination and that federal/state law and contract provisions take precedence.

OpenPayer

April 2026 Revision: Coverage Clarifications and Modality Specification

What changed in this revision

Coverage Scope: Photon-Based External Beam Indications

Eligible indication: hydrogel spacer with photon external beam radiation

Noncoverage: Brachytherapy, Proton Beam Therapy, and Other Indications

Explicit non-covered indications: brachytherapy and proton therapy

Definitions and Priority of Contract/Legal Provisions

Medical necessity definition and policy hierarchy